Progressive Changes in the Leukemogenic Signaling in BCR/ABL-transformed Cells

Oncogene - United Kingdom
doi 10.1038/sj.onc.1203754
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

BCR-ABL-transformed GMP as Myeloid Leukemic Stem Cells

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

Genomic Mechanisms of P210 BCR-ABL Signaling

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2004English

Protein Kinase CKIIa Interacts With the BCR Moiety of BCR/Abl and Mediates Proliferation of BCR/Abl-Expressing Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
2004English

MT1-MMP as a Downstream Target of BCR-ABL/ABL Interactor 1 Signaling: Polarized Distribution and Involvement in BCR-ABL-stimulated Leukemic Cell Migration

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2007English

Reciprocal T(9;22) ABL/BCR Fusion Proteins: Leukemogenic Potential and Effects on B Cell Commitment

PLoS ONE
Multidisciplinary
2009English

Bcr: A Negative Regulator of the BCR-Abl Oncoprotein in Leukemia

Oncogene
Cancer ResearchGeneticsMolecular Biology
2002English

WNT/Ca2+/Nfat Signaling Maintains Survival of Ph+ Leukemia Cells Upon Inhibition of BCR-Abl

Cancer Cell
Cancer ResearchOncologyCell Biology
2010English

The BCR-Abl Tyrosine Kinase Activates Mitogenic Signaling Pathways and Stimulates G1-To-S Phase Transition in Hematopoietic Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
1997English

BCR-ABL Tyrosine Kinase

Science-Business eXchange
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy